1107 related articles for article (PubMed ID: 19040546)
1. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
2. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
3. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
5. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
6. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
8. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
10. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results.
Cox JT
J Clin Virol; 2009 Jul; 45 Suppl 1():S3-S12. PubMed ID: 19651367
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
12. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
Alanen KW; Elit LM; Molinaro PA; McLachlin CM
Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
[TBL] [Abstract][Full Text] [Related]
14. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
15. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
Case AS; Rocconi RP; Straughn JM; Wang W; Roark K; Waltman EE; Huh WK
Obstet Gynecol; 2006 Dec; 108(6):1369-74. PubMed ID: 17138768
[TBL] [Abstract][Full Text] [Related]
16. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
17. Significance of atypical cervical cytology in pregnancy.
Kaminski PF; Lyon DS; Sorosky JI; Wheelock JB; Podczaski ES
Am J Perinatol; 1992; 9(5-6):340-3. PubMed ID: 1418129
[TBL] [Abstract][Full Text] [Related]
18. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance].
Zhao J; Zhou JN; Yang YJ; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350
[TBL] [Abstract][Full Text] [Related]
19. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
[TBL] [Abstract][Full Text] [Related]
20. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
